160 related articles for article (PubMed ID: 30554617)
1. Pharmaceutical companies and medical practitioners or "the beast and the beauty"?
Villalba L
Clin Dermatol; 2019; 37(1):16-20. PubMed ID: 30554617
[TBL] [Abstract][Full Text] [Related]
2. Information from pharmaceutical companies and the quality, quantity, and cost of physicians' prescribing: a systematic review.
Spurling GK; Mansfield PR; Montgomery BD; Lexchin J; Doust J; Othman N; Vitry AI
PLoS Med; 2010 Oct; 7(10):e1000352. PubMed ID: 20976098
[TBL] [Abstract][Full Text] [Related]
3. Attitudes and practices of medical graduates in Delhi towards gifts from the pharmaceutical industry.
Sharma V; Aggarwal S; Singh H; Garg S; Sharma A; Sharma R
Indian J Med Ethics; 2010; 7(4):223-5. PubMed ID: 22106572
[TBL] [Abstract][Full Text] [Related]
4. [Conflicts of interest, an insidious blight on medicine].
Altisent R
Aten Primaria; 2019 Oct; 51(8):469-470. PubMed ID: 31202475
[No Abstract] [Full Text] [Related]
5. Interactions between physicians and the pharmaceutical industry generally and sales representatives specifically and their association with physicians' attitudes and prescribing habits: a systematic review.
Fickweiler F; Fickweiler W; Urbach E
BMJ Open; 2017 Sep; 7(9):e016408. PubMed ID: 28963287
[TBL] [Abstract][Full Text] [Related]
6. Double standards in clinical practice ethics.
Harris IA; Naylor JM
Med J Aust; 2014 Feb; 200(2):76. PubMed ID: 24484092
[No Abstract] [Full Text] [Related]
7. Drug promotion tactics-yet another pharma deception?
Tagore A
Int J Clin Pract; 2014 Jun; 68(6):662-5. PubMed ID: 24837088
[TBL] [Abstract][Full Text] [Related]
8. No more free lunches.
Abbasi K; Smith R
BMJ; 2003 May; 326(7400):1155-6. PubMed ID: 12775587
[No Abstract] [Full Text] [Related]
9. Doctors and drug companies: still cozy after all these years.
Henry D
PLoS Med; 2010 Nov; 7(11):e1000359. PubMed ID: 21072244
[TBL] [Abstract][Full Text] [Related]
10. Ethics for the pediatrician: physician interaction with the pharmaceutical industry.
Cicero MX; Curi MB; Mercurio M
Pediatr Rev; 2011 Jan; 32(1):e1-3. PubMed ID: 21196498
[No Abstract] [Full Text] [Related]
11. An ophthalmology code of ethics in Canada: enhancing our practice patterns.
McAlister C; Braga-Mele R; El-Defrawy S; Hillson T
Can J Ophthalmol; 2015 Aug; 50(4):253-4. PubMed ID: 26257215
[No Abstract] [Full Text] [Related]
12. After 20 years, industry critics bury skeptics, despite empirical vacuum.
Barton D; Stossel T; Stell L
Int J Clin Pract; 2014 Jun; 68(6):666-73. PubMed ID: 24837089
[TBL] [Abstract][Full Text] [Related]
13. Should physicians rely on pharmaceutical detailing for their education?
van Schalkwyk JM; Turner MJ
J Clin Hypertens (Greenwich); 2013 Mar; 15(3):218. PubMed ID: 23458597
[No Abstract] [Full Text] [Related]
14. [I forbid, therefore I assist].
Grinberg M
Arq Bras Cardiol; 2005 Oct; 85(4):283-6. PubMed ID: 16283036
[No Abstract] [Full Text] [Related]
15. The ethics of expediency.
Glickel SZ
J Hand Surg Am; 2009; 34(5):799-807. PubMed ID: 19410982
[TBL] [Abstract][Full Text] [Related]
16. Physician Exposure to Direct-to-Consumer Pharmaceutical Marketing: Potential for Creating Prescribing Bias.
Brown JL
Am J Med; 2017 Jun; 130(6):e247-e248. PubMed ID: 28089801
[No Abstract] [Full Text] [Related]
17. Clarifying the costs of conflicts of interest.
Mayes C; Lipworth W; Kerridge I
Int J Clin Pract; 2015 Mar; 69(3):384-5. PubMed ID: 25727803
[No Abstract] [Full Text] [Related]
18. Pharmaism: a tale of two perspectives.
Citrome L; Karagianis J; Maguire GA; Nierenberg AA
Int J Clin Pract; 2014 Jun; 68(6):659-61. PubMed ID: 24837087
[No Abstract] [Full Text] [Related]
19. Response to clarifying the costs of conflicts of interest.
Stossel TP; Barton DW; Stell LK
Int J Clin Pract; 2015 Mar; 69(3):385-6. PubMed ID: 25727804
[No Abstract] [Full Text] [Related]
20. The value and challenges of collegiality in practice.
Burr SA; Collett T; Leung YL
Br J Hosp Med (Lond); 2017 Sep; 78(9):486-487. PubMed ID: 28898155
[No Abstract] [Full Text] [Related]
[Next] [New Search]
